These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


190 related items for PubMed ID: 6097709

  • 1. Successful allogeneic bone marrow transplantation for three children with acute nonlymphocytic leukemia.
    Ohira M, Takayama J, Hanada M.
    Jpn J Clin Oncol; 1984 Dec; 14 Suppl 1():487-93. PubMed ID: 6097709
    [Abstract] [Full Text] [Related]

  • 2. Marrow transplantation for acute nonlymphocytic leukemia after treatment with busulfan and cyclophosphamide.
    Santos GW, Tutschka PJ, Brookmeyer R, Saral R, Beschorner WE, Bias WB, Braine HG, Burns WH, Elfenbein GJ, Kaizer H.
    N Engl J Med; 1983 Dec 01; 309(22):1347-53. PubMed ID: 6355849
    [Abstract] [Full Text] [Related]

  • 3. Allogeneic bone marrow transplantation for children with acute leukemia: long-term follow-up of patients prepared with high-dose cytosine arabinoside and fractionated total body irradiation.
    Gordon BG, Warkentin PI, Strandjord SE, Abromowitch M, Bayever E, Harper JL, Coccia PF.
    Bone Marrow Transplant; 1997 Jul 01; 20(1):5-10. PubMed ID: 9232249
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Sixteen adult patients with acute leukemia treated by chemotherapy, total body irradiation and allogeneic marrow transplantation.
    Kodera Y, Morishima Y, Morishita Y, Murase T, Okumura M, Yamada H, Minami S, Kato Y, Ogura M, Nagura E.
    Jpn J Clin Oncol; 1984 Dec 01; 14 Suppl 1():479-85. PubMed ID: 6394811
    [Abstract] [Full Text] [Related]

  • 7. Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide.
    Duerst RE, Horan JT, Liesveld JL, Abboud CN, Zwetsch LM, Senf ES, Constine LS, Raubertas RF, Passarell JA, DiPersio JF.
    Bone Marrow Transplant; 2000 Mar 01; 25(5):489-94. PubMed ID: 10713624
    [Abstract] [Full Text] [Related]

  • 8. Bone-marrow ablation and allogeneic marrow transplantation in acute leukemia.
    Blume KG, Beutler E, Bross KJ, Chillar RK, Ellington OB, Fahey JL, Farbstein MJ, Forman SJ, Schmidt GM, Scott EP, Spruce WE, Turner MA, Wolf JL.
    N Engl J Med; 1980 May 08; 302(19):1041-6. PubMed ID: 6245359
    [Abstract] [Full Text] [Related]

  • 9. Allogeneic bone marrow transplantation in children: Tokai experience 1982 to 1984.
    Kato S, Hoshi N, Nagasaka M, Muranaka S, Yabe H, Kimura M.
    Tokai J Exp Clin Med; 1985 Jun 08; 10(2-3):147-58. PubMed ID: 3010509
    [Abstract] [Full Text] [Related]

  • 10. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors.
    Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J.
    Biol Blood Marrow Transplant; 1997 Apr 08; 3(1):11-7. PubMed ID: 9209736
    [Abstract] [Full Text] [Related]

  • 11. Statistical analysis of favorable prognostic factors in allogeneic bone marrow transplantation for acute leukemia in Japan.
    Inoue T, Masaoka T, Mori T, Katoh S, Saito Y, Harada M, Saito M, Moriyama Y, Ohira M, Morita K.
    Jpn J Clin Oncol; 1984 Dec 08; 14 Suppl 1():563-71. PubMed ID: 6394817
    [Abstract] [Full Text] [Related]

  • 12. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.
    Mehta J, Powles R, Treleaven J, Horton C, Tait D, Meller S, Pinkerton CR, Middleton G, Eisen T, Singhal S.
    Bone Marrow Transplant; 1996 Oct 08; 18(4):741-6. PubMed ID: 8899189
    [Abstract] [Full Text] [Related]

  • 13. [Whole body irradiation in conditioning for bone marrow transplantation. Experiences with 35 cases of leukemia].
    Prosperini G, Santeusanio E, Di Bartolomeo P, Iacone A, Muzii G.
    Radiol Med; 1985 Apr 08; 71(4):243-7. PubMed ID: 3901148
    [Abstract] [Full Text] [Related]

  • 14. Indications for bone marrow grafting.
    Boiron M, Gluckman E.
    Bull Cancer; 1981 Apr 08; 68(1):59-62. PubMed ID: 7013867
    [Abstract] [Full Text] [Related]

  • 15. Bone marrow transplantation for chronic myeloid leukemia (CML) from unrelated and sibling donors: single center experience.
    Lamparelli T, Van Lint MT, Gualandi F, Occhini D, Barbanti M, Sacchi N, Ficai G, Ghinatti C, Ferrara GB, Delfino L, Pozzi S, Morabito A, Zikos P, Vitale V, Corvo R, Frassoni F, Bacigalupo A.
    Bone Marrow Transplant; 1997 Dec 08; 20(12):1057-62. PubMed ID: 9466278
    [Abstract] [Full Text] [Related]

  • 16. Use of recombinant human granulocyte colony-stimulating factor in children given allogeneic bone marrow transplantation for acute or chronic leukemia.
    Locatelli F, Pession A, Zecca M, Bonetti F, Prete L, Carrà AM, Prete A, Montagna D, Comoli P, Taibi RM, Paolucci G.
    Bone Marrow Transplant; 1996 Jan 08; 17(1):31-7. PubMed ID: 8673051
    [Abstract] [Full Text] [Related]

  • 17. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F, Copelan E, Crilley P, Bolwell B, Avalos B, Klein J, Territo M, Gajewski J.
    Bone Marrow Transplant; 1996 May 08; 17(5):685-9. PubMed ID: 8733682
    [Abstract] [Full Text] [Related]

  • 18. The impact of partial T cell depletion on overall transplant-related toxicity, graft function and survival after HLA-identical allogeneic bone marrow transplantation in standard risk adult patients with leukemia.
    Schots R, Van Riet I, Ben Othman T, Trullemans F, De Waele M, Van Camp B.
    Bone Marrow Transplant; 2001 Nov 08; 28(10):917-22. PubMed ID: 11753544
    [Abstract] [Full Text] [Related]

  • 19. Allogeneic bone marrow transplantation for acute myeloblastic leukaemia in remission: risk factors for long-term morbidity and mortality.
    Robin M, Guardiola P, Dombret H, Baruchel A, Esperou H, Ribaud P, Devergie A, Gluckman E, Socié G.
    Bone Marrow Transplant; 2003 May 08; 31(10):877-87. PubMed ID: 12748664
    [Abstract] [Full Text] [Related]

  • 20. Leukemia-free survival and mortality in patients with refractory or relapsed acute leukemia given marrow transplants from sibling and unrelated donors.
    Greinix HT, Reiter E, Keil F, Fischer G, Lechner K, Dieckmann K, Leitner G, Schulenburg A, Hoecker P, Haas OA, Knoebl P, Mannhalter C, Fonatsch C, Hinterberger W, Kalhs P.
    Bone Marrow Transplant; 1998 Apr 08; 21(7):673-8. PubMed ID: 9578306
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.